CEACAM19 Antibody (HY-8H10) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88978
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # HY-8H10
Format
Azide and BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Vector containing the cDNA of human CEACAM19.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Description
Novus Biologicals Mouse CEACAM19 Antibody (HY-8H10) - Azide and BSA Free (NBP2-88978) is a monoclonal antibody validated for use in ELISA and Flow. All Novus Biologicals antibodies are covered by our 100% guarantee.
Applications for CEACAM19 Antibody (HY-8H10) - Azide and BSA Free
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Competitive ELISA: 1:200-1:400
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS , pH 7.2
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CEACAM-19
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 19
Alternate Names
CEACAM19, CEAL1
Gene Symbol
CEACAM19
Additional CEACAM-19 Products
Product Documents for CEACAM19 Antibody (HY-8H10) - Azide and BSA Free
Product Specific Notices for CEACAM19 Antibody (HY-8H10) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...